Stocks / NASDAQ / Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc.

Our Opinion

Coeptis Therapeutics Holdings Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Company Description

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn’s disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Company Website: